Cancer patients on the Isle of Wight are benefiting from faster treatment and shorter hospital stays. Improvements at St Mary’s Hospital mean patients who previously needed overnight care can now ...

Moby Strategic Execution and Commercial Foundation. Management attributes the early 2025 Zasturi revenue of $15.8 million to a d ...

Bladder cancer frequently announces itself through symptoms that patients dismiss as minor urinary issues, and that delay ...

EORTC Recurrence Score Analysis from the Pivotal ENVISION Trial to be Presented at the 2026 American Society of Clinical Oncology’s ...

Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk ...

UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2025 Earnings Call Transcript August 9, 2025 Operator: Good day, and thank you for standing by. Welcome to the UroGen Pharma Second Quarter 2025 Earnings Call.

Commercial launch is on-track for ZUSDURI, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC); net sales ...

MINNEAPOLIS, Feb. 3, 2026 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company, announced the first commercial procedure using the Vanquish Water Vapor Ablation System at ...

Active surveillance is noninferior to BCG induction therapy for invasive relapse-free survival in patients with high-grade T1 bladder cancer with no residual tumor on second TURBT. For patients with ...

The organization’s latest guidance is a departure from the prevailing views of several other major medical organizations. By Andrew Jacobs The American Society of Plastic Surgeons recommended on ...

Septal myectomy removes part of a thickened septum to treat hypertrophic cardiomyopathy (HCM) with left ventricular outflow tract obstruction. It can improve severe symptoms that do not respond to ...